Novavax, Inc.
NVAX
$8.05
-$0.09-1.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -158.59% | -118.35% | 334.83% | 219.97% | 243.65% |
| Total Depreciation and Amortization | -56.64% | -50.02% | -43.06% | -25.16% | -9.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,240.71% | 1,050.18% | 5,276.15% | 7.93% | -111.68% |
| Change in Net Operating Assets | 103.14% | 76.13% | -1,931.00% | -1,914.80% | -851.28% |
| Cash from Operations | 94.15% | 51.61% | -180.34% | -316.28% | -4,518.97% |
| Capital Expenditure | -9.68% | 24.23% | 52.40% | 69.59% | 85.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -491.07% | 93.97% | 81.22% | 58.09% | 107.14% |
| Cash from Investing | -151.25% | 87.67% | 61.64% | 112.67% | 152.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -37.51% | -44.78% | -152.15% | -84.23% | -372.49% |
| Issuance of Common Stock | 1,590.36% | -97.95% | -98.01% | -98.56% | -99.93% |
| Repurchase of Common Stock | -37.02% | -55.37% | -693.99% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -878.90% | -- | -- | -- |
| Cash from Financing | 742.98% | -70.73% | -89.36% | -91.51% | -102.07% |
| Foreign Exchange rate Adjustments | -154.44% | 218.39% | 175.96% | -152.85% | -75.01% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.90% | 79.05% | -650.92% | -292.45% | -340.17% |